EUVIMEDEUVIMED entdecken
Crossref

Integrated Risk Prediction of Kidney Failure

Alana C Jones iD, Atlas Khan iD, Amit Patki iD, Vinodh Srinivasasainagendra, Nicole D Armstrong iD, Hemant K Tiwari iD, Bertha A Hidalgo iD, Nita A Limdi iD, Donna K Arnett, Devin M Absher iD, Krzysztof Kiryluk iD, Brittney Davis iD und 6 weitere

Clinical Journal of the American Society of Nephrology · 28.09.2026

DOI: 10.2215/cjn.0000001217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 28.09.2026. Verfasst von Alana C Jones und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Die Arbeit nennt 31 Literaturangaben. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points An integrative risk framework with genomic, epigenomic, and clinical factors was developed to predict risk of new-onset kidney failure in a study. Addition of polygenic and methylation information to a clinical risk score modestly improved the prediction of kidney failure. Polygenic and methylation risk scores alone were not superior to a clinical risk algorithm.

Background

Kidney failure affects approximately 800,000 adults in the United States, and African American individuals carry a disproportionate burden of disease. Robust algorithms for clinical risk prediction, such as the kidney failure risk equation (KFRE), have previously been validated, whereas the clinical utility of polygenic risk scores (PRS) and methylation risk scores (MRS) have not been as well characterized.

Methods

In this study, we evaluated the capacity of PRS and MRS for CKD to predict multiple clinical end points, including incident kidney failure and decline in kidney function. Leveraging genomic, epigenomic, and clinical data from African American participants of the Hypertension Genetic Epidemiology Network (HyperGEN), Multi-Ethnic Study of Atherosclerosis (MESA), and Electronic Medical Records and Genomics Network, we evaluated the performance of these risk scores in comparison with and in conjunction with the widely validated KFRE.

Results

In HyperGEN, a higher PRS was associated with a higher risk of kidney failure. Similarly, the MRS was associated with incident kidney failure in both HyperGEN and MESA. Neither PRS nor MRS were associated with the rate of decline in kidney function in Electronic Medical Records and Genomics or MESA. The KFRE outperformed both PRS and MRS as a single predictor. However, multiscore models suggested a synergistic effect of PRS and MRS to the predictive accuracy of the KFRE, with the greatest risk of kidney failure among individuals in high-risk strata of KFRE, PRS, and MRS.

Conclusions

Results from this exploratory analysis suggest that, although PRS and MRS may not be superior to clinical algorithms, inclusion of -omics information may improve disease risk prediction. Future studies should seek to increase sample size to better evaluate these risk models and improve their capacity.

Schlagwörter

Stichwörter der Autor:innen

CKDESKDchronic kidney failurechronic renal diseasechronic renal failurecohort studiesepidemiologic methodsepidemiology and outcomesgenetics and development

Autor:innen und Institutionen

  • Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Division of Nephrology, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
  • Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama.
  • Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama.
  • School of Public Health, University of South Carolina, Columbia, South Carolina.

ORCID-Profile: Alana C Jones, Atlas Khan, Amit Patki, Nicole D Armstrong, Hemant K Tiwari, Bertha A Hidalgo, Nita A Limdi, Devin M Absher, Krzysztof Kiryluk, Brittney Davis, Stephen S Rich, Jerome I Rotter, Josyf Mychaleckyj, Yongmei Liu

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NHGRI NIH HHS
  • Broad Institute
  • TOPMed Informatics Research Center
  • U.S. Department of Health and Human Services
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Jones, A. C., Khan, A., Patki, A., Srinivasasainagendra, V., Armstrong, N. D., Tiwari, H. K., Hidalgo, B. A., Limdi, N. A., Arnett, D. K., Absher, D. M., Kiryluk, K., Davis, B., Rich, S. S., Rotter, J. I., Mychaleckyj, J., Kramer, H. J., Liu, Y., & Irvin, M. R. (2026). Integrated Risk Prediction of Kidney Failure. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001217

Vancouver

Jones AC, Khan A, Patki A, Srinivasasainagendra V, Armstrong ND, Tiwari HK, et al. Integrated Risk Prediction of Kidney Failure. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001217

BibTeX
@article{Jones2026,
  author = {Jones, Alana C and Khan, Atlas and Patki, Amit and Srinivasasainagendra, Vinodh and Armstrong, Nicole D and Tiwari, Hemant K and Hidalgo, Bertha A and Limdi, Nita A and Arnett, Donna K and Absher, Devin M and Kiryluk, Krzysztof and Davis, Brittney and Rich, Stephen S and Rotter, Jerome I and Mychaleckyj, Josyf and Kramer, Holly J and Liu, Yongmei and Irvin, Marguerite R},
  title = {Integrated Risk Prediction of Kidney Failure},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001217}
}
Kostenlos starten →